VBS — Vectus Biosystems Income Statement
0.000.00%
Last trade - 00:00
- AU$14.63m
- AU$12.61m
- AU$0.06m
2019 June 30th | 2020 June 30th | R2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0.001 | 0 | 0 | 0.056 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 2.37 | 2.66 | 3.75 | 4.6 | 4.6 |
Operating Profit | -2.37 | -2.66 | -3.75 | -4.6 | -4.54 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -2.5 | -3.38 | -3.86 | -3.99 | -3.45 |
Provision for Income Taxes | |||||
Net Income After Taxes | -1.6 | -3 | -3.86 | -3.99 | -3.45 |
Net Income Before Extraordinary Items | |||||
Net Income | -1.6 | -3 | -3.86 | -3.99 | -3.45 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -1.6 | -3 | -3.86 | -3.99 | -3.45 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.068 | -0.129 | -0.139 | -0.12 | -0.072 |